首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1692359

馬用藥品和補品市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、配銷通路、地區和競爭細分，2020-2030 年預測

Equine Pharmaceuticals & Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region & Competition, 2020-2030F

出版日期: 2025年03月24日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球馬用藥品和補充劑市場價值為 9.7289 億美元，預計在預測期內將經歷大幅成長，到 2030 年預計年複合成長率(CAGR) 為 5.90%。該市場包括旨在促進馬匹健康和福祉的各種產品和服務。它涵蓋專為馬匹設計的藥品、營養補充劑和醫療保健服務，目的是維持馬匹的健康、提高馬匹的性能並解決各種醫療狀況。例如，2024年3月，美國馬獸醫協會（AAEP）發布了針對美國流行的五種重大馬病的更新疫苗接種方案，這些疾病——西尼羅河病毒、破傷風、馬腦脊髓炎和狂犬病——的方案旨在加強預防工作，確保全國馬匹的健康和安全。

市場概況
預測期	2026-2030
2024 年市場規模	9.7289億美元
2030 年市場規模	13.6115億美元
2025-2030 年複合年成長率	5.90％
成長最快的領域	製藥
最大的市場	北美洲

主要市場促進因素：

增加馬匹數量

主要市場挑戰：

仿冒品

主要市場趨勢：

天然和草藥補充劑

The global Equine Pharmaceuticals & Supplements market was valued at USD 972.89 million in 2024 and is expected to experience substantial growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market includes a wide range of products and services aimed at promoting the health and well-being of horses. It encompasses pharmaceuticals, nutritional supplements, and healthcare services specifically designed for equines, with the goal of maintaining their health, improving performance, and addressing various medical conditions. For example, in March 2024, the American Association of Equine Practitioners (AAEP) released updated vaccination protocols for five critical equine diseases prevalent in the U.S. These diseases-West Nile virus, tetanus, equine encephalomyelitis, and rabies-have protocols designed to improve prevention efforts and ensure the health and safety of horses nationwide.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 972.89 Million
Market Size 2030	USD 1361.15 Million
CAGR 2025-2030	5.90%
Fastest Growing Segment	Pharmaceutical
Largest Market	North America

Key Market Drivers:

Increasing Equine Population

The global equine industry has seen a notable and steady rise in the equine population, which has significantly influenced the growth of the Equine Pharmaceuticals & Supplements market. There has been a marked increase in participation in equestrian activities such as horse riding, show jumping, and dressage, leading to a higher demand for horses for both sporting and recreational purposes. Beyond sports and leisure, horses are vital in industries such as agriculture, tourism, therapy, and law enforcement. As these sectors grow, the need for a larger equine workforce has also increased. Additionally, horses have become increasingly popular as companion animals, contributing to a surge in ownership.

Key Market Challenges:

Counterfeit Products

The presence of counterfeit equine pharmaceuticals and supplements remains a significant challenge. These products are often of subpar quality, containing incorrect ingredients or dosages, which could endanger the health of horses and undermine consumer confidence in the market.

Key Market Trends:

Natural and Herbal Supplements

A growing trend within the equine supplements market is the rising demand for natural and herbal alternatives. Horse owners are increasingly seeking holistic solutions to equine health, opting for supplements made from herbs, botanicals, and plant-based ingredients known for their therapeutic benefits. These products are perceived as gentler alternatives to conventional pharmaceuticals.

Key Market Players:

Zoetis Inc
Boehringer Ingelheim GmbH
Merck & Co Inc
Elanco Animal Health Inc
Bayer AG
Ceva Sante Animale SA
Virbac SA
Vetoquinol SA
Affymetrix Inc
Celltrion Inc

Report Scope:

This report segments the global Equine Pharmaceuticals & Supplements market into the following categories, and provides insights into the industry trends:

By Product:

Pharmaceuticals
Supplements

By Distribution Channel:

Drug Stores
Veterinary Hospitals
Other Channels

By Region:

North America: United States, Canada, Mexico
Europe: Germany, United Kingdom, France, Italy, Spain
Asia-Pacific: China, Japan, India, Australia, South Korea
South America: Brazil, Argentina, Colombia
Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section provides a detailed analysis of the key players in the global Equine Pharmaceuticals & Supplements market.

Available Customizations:

TechSci Research offers customized reports based on specific market data for the Global Equine Pharmaceuticals & Supplements market, catering to individual business needs. Customization options include the profiling and analysis of additional market players (up to five).

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Pharmaceuticals & Supplements Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Pharmaceutical, Supplement)
- 5.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Product Market Map
- 5.3.1. By Product
- 5.3.2. By Distribution Channel
- 5.3.3. By Region

6. North America Equine Pharmaceuticals & Supplements Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product (Pharmaceutical, Supplement)
- 6.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Equine Pharmaceuticals & Supplements Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Distribution Channel
- 6.3.2. Canada Equine Pharmaceuticals & Supplements Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Distribution Channel
- 6.3.3. Mexico Equine Pharmaceuticals & Supplements Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Distribution Channel

7. Europe Equine Pharmaceuticals & Supplements Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product (Pharmaceutical, Supplement)
- 7.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Equine Pharmaceuticals & Supplements Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Distribution Channel
- 7.3.2. United Kingdom Equine Pharmaceuticals & Supplements Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Distribution Channel
- 7.3.3. France Equine Pharmaceuticals & Supplements Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Distribution Channel
- 7.3.4. Italy Equine Pharmaceuticals & Supplements Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Distribution Channel
- 7.3.5. Spain Equine Pharmaceuticals & Supplements Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Equine Pharmaceuticals & Supplements Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product (Pharmaceutical, Supplement)
- 8.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Equine Pharmaceuticals & Supplements Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Distribution Channel
- 8.3.2. Japan Equine Pharmaceuticals & Supplements Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Distribution Channel
- 8.3.3. India Equine Pharmaceuticals & Supplements Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Distribution Channel
- 8.3.4. Australia Equine Pharmaceuticals & Supplements Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Distribution Channel
- 8.3.5. South Korea Equine Pharmaceuticals & Supplements Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Distribution Channel

9. South America Equine Pharmaceuticals & Supplements Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product (Pharmaceutical, Supplement)
- 9.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Equine Pharmaceuticals & Supplements Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Distribution Channel
- 9.3.2. Argentina Equine Pharmaceuticals & Supplements Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Distribution Channel
- 9.3.3. Colombia Equine Pharmaceuticals & Supplements Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Equine Pharmaceuticals & Supplements Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product (Pharmaceutical, Supplement)
- 10.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Equine Pharmaceuticals & Supplements Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Distribution Channel
- 10.3.2. Saudi Arabia Equine Pharmaceuticals & Supplements Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Distribution Channel
- 10.3.3. UAE Equine Pharmaceuticals & Supplements Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Distribution Channel
- 10.3.4. Kuwait Equine Pharmaceuticals & Supplements Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Product
    - 10.3.4.2.2. By Distribution Channel